These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 23318908

  • 1. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R.
    Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L, Malpica A, Deavers MT, Guo M, Villa LL, Nuovo G, Merino MJ, Silva EG.
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM.
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [Abstract] [Full Text] [Related]

  • 7. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS, Mashhour M, Noftech-Mozes S, Ismiil N, Dubé V, Ghorab Z, Faragalla H, Khalifa MA.
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
    Liao CL, Hsu JD, Lee MY, Kok LF, Li YJ, Wang PH, Yao CC, Han CP.
    Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T, Ohishi Y, Kaku T, Aman M, Imamura H, Yasutake N, Sonoda K, Kato K, Oda Y.
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [Abstract] [Full Text] [Related]

  • 18. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.
    Castrillon DH, Lee KR, Nucci MR.
    Int J Gynecol Pathol; 2002 Jan; 21(1):4-10. PubMed ID: 11781516
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N, Yamamoto H, Kuga R, Jiromaru R, Hongo T, Katayama Y, Sonoda K, Yahata H, Kato K, Oda Y.
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.